Anu Suomalainen Wartiovaara - Curriculum Vitae#

EDUCATION/DEGREES

• Docent, University of Helsinki, Helsinki, Finland, 02/6/1997
  
• PhD, University of Helsinki, Helsinki, Finland, 26/3/1993
  
• Legalized physician, State Bureau of Medicolegal affairs, Helsinki, Finland, 1992
  
• MD, University of Helsinki, Helsinki, Finland, 10/9/1991

Scientific POSITIONS

• Academy Professor, Academy of Finland and UHel, 2017 - 2021 and 2022 - 2026
  
• Professor of Clinical Molecular Medicine UHel, Finland, 1/2007
  
• Chief physician, 20%, HUSLab Diagnostic, Helsinki University Hospital, Finland, 1/2007
  
• Associate Editor, EMBO Mol Med 8/2014; Cell Stress 2018; Cell Metab 2020; Trends Mol Med 2020; Principal
  
• Chair oft he Board, NADMED startup 2022->
  
• Director, Research Program of Molecular Neurology, UHel, Finland, 1/2004 - 12/2018
  
• Visiting Professor, LiKa Shing Centre; UC Berkeley, USA, 8/2014 - 6/2015
  
• Member of the Health Research Council, Academy of Finland, Finland, 1/2013 - 5/2017
  
• Sigrid Juselius Professor UHel, Finland, 1/2007 - 12/2016
  
• Senior research fellow, Academy of Finland 8/2002 - 12/2006
  
• Postdoctoral fellow McGill Uni, Montreal Neurological Inst, Canada, 10/1998 - 5/2001
  
• Research scientist NPHI, Helsinki, Finland, 1993 - 1998
  
• PhD student NPHI , Helsinki, Finland, 6/1989 - 3/1993

PUBLICATIONS

212 scientific publications; 181 peer-reviewed publications (Web of Science Oct 2021). H-index 61. Cited: 13357; Most cited publications Cell 2012 (1437 times )Nat Genet 2001 (611); Science 2000 (456). Mean of 73,8 citations per publication.

PATENTS

• 2020 Patent application NADmed (20205738)
  
• 2019 Innovation disclosure: MitoComMove application.
  
• 2018 Patent application, Biomarkers for mitochondrial diseases (20185846)